For the vast majority of users, Poliglo causes no issues at all
Treatment approach: PRP therapy may help stimulate regrowth
Then, keep up with injections every 1-3 months
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
Most preclinical studies utilize supraphysiologic doses, alternate routes of administration and short follow-up windows that do not mimic human reproductive timelines
report successful normalization of plasma B12 levels in pediatric patients with various cobalamin deficiencies using subcutaneous hydroxocobalamin (OH-Cbl)